adenine and sulprostone

adenine has been researched along with sulprostone in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
An, S; Goetzl, EJ; Zeng, L1
Créminon, C; Levi, G; Maclouf, J; Minghetti, L; Nicolini, A; Polazzi, E1
Bai, XM; Chen, M; Guo, Y; Leng, J; Ma, J; Shu, W; Wang, YH; Wang, YP; Xia, SK; Xu, Y; Zhang, H; Zhang, L; Zhang, M1

Other Studies

3 other study(ies) available for adenine and sulprostone

ArticleYear
Regulation of expression of matrix metalloproteinase-9 in early human T cells of the HSB.2 cultured line by the EP3 subtype of prostaglandin E2 receptor.
    The Journal of biological chemistry, 1996, Nov-01, Volume: 271, Issue:44

    Topics: Adenine; Alprostadil; Blotting, Northern; Bucladesine; Calcium; Cell Line; Colforsin; Collagenases; Cyclic AMP; Cycloheximide; Dactinomycin; Dinoprostone; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Leukemia, T-Cell; Matrix Metalloproteinase 9; Misoprostol; Prostaglandins E, Synthetic; Receptors, Prostaglandin E; RNA, Messenger; T-Lymphocytes; Thapsigargin; Transcription, Genetic; Tumor Cells, Cultured

1996
Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors.
    Glia, 1997, Volume: 19, Issue:2

    Topics: Adenine; Adenylyl Cyclase Inhibitors; Amino Acid Sequence; Animals; Bucladesine; Cells, Cultured; Cyclic AMP; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Inhibitors; Lipopolysaccharides; Menstruation-Inducing Agents; Microglia; Molecular Sequence Data; Nitric Oxide Synthase; Rats; Receptors, Prostaglandin

1997
Prostaglandin E2 promotes liver cancer cell growth by the upregulation of FUSE-binding protein 1 expression.
    International journal of oncology, 2013, Volume: 42, Issue:3

    Topics: Abortifacient Agents, Nonsteroidal; Adenine; Adenylyl Cyclase Inhibitors; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colforsin; Cyclic AMP; Dinoprostone; DNA Helicases; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Humans; Isoquinolines; Liver Neoplasms; Nuclear Proteins; Pertussis Toxin; Phosphorylation; Protein Kinase Inhibitors; Receptors, Prostaglandin E, EP3 Subtype; Receptors, Prostaglandin E, EP4 Subtype; RNA Interference; RNA-Binding Proteins; RNA, Small Interfering; Smad2 Protein; Sulfonamides; Ubiquitination

2013